| Product Name | MF | CAS | Details |
|---|
| N-(3,4-DICHLOROPHENYL)-2-(2-(1H-INDOL-3-YLMETHYLENE)HYDRAZINO)-2-OXOACETAMIDE | C17H12Cl2N4O2 | 765275-50-1 | Details |
| (2,2,2-TRICHLORO-1-(3-O-TOLYL-THIOUREIDO)-ETHYL)-CARBAMIC ACID ETHYL ESTER | 297141-07-2 | Details |
| 3-Hydroxy- |
C10H12N2O4 | 1313734-57-4 | Details |
| 8-AMINO-1,3-DIMETHYL-7-(1-NAPHTHYLMETHYL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE | C18H17N5O2 | 476480-20-3 | Details |
| (1R,2S)-2-(2-HYDROXY-3-PENTYNYL)-3-CYCLOPENTEN-1-OL | C10H14O2 | 1217494-90-0 | Details |
| MMPIP | C19H15N3O3 | 479077-02-6 | Details |
| 3-PHENYL-4,5,6-TRICHLORO-2-INDOLINONE | 201216-23-1 | Details |
| N-(4-((2,4-DIMETHOXY-BENZYLIDENE)-AMINO)-PHENYL)-ACETAMIDE | C17H18N2O3 | 329934-20-5 | Details |
| 2-[5-(4-FLUOROPHENYL)-3-(2-THIENYL)-4,5-DIHYDRO-1H-PYRAZOL-1-YL]-4-PHENYL-1,3-THIAZOLE | C22H16FN3S2 | 296773-31-4 | Details |
| N'(1),N'(10)-BIS(2-(BENZYLOXY)BENZYLIDENE)DECANEDIHYDRAZIDE | C38H42N4O4 | 374692-50-9 | Details |
| METHYL (2E)-2-(2-FLUOROBENZYLIDENE)-7-METHYL-3-OXO-5-(2-THIENYL)-2,3-DIHYDRO-5H-[1,3]THIAZOLO[3,2-A]PYRIMIDINE-6-CARBOXYLATE | C20H15FN2O3S2 | 324071-32-1 | Details |
| Lawesson reagent | C14H14O2P2S4 | 19172-47-5 | Details |
| (16alpha)-3-methoxyestra-1(10),2,4-trien-16-ol | Details |
| RCL T188905 | C17H15N3O2 | 53945-68-9 | Details |
| 17:0-22:4 PI-d5 | C48H88NO13P | 2342575-39-5 | Details |
| 3-(3,4-DIMETHOXYPHENYL)-N-(2-METHOXY-4-NITROPHENYL)ACRYLAMIDE | C18H18N2O6 | 302549-42-4 | Details |
| Arjunetin | C36H58O10 | 31297-79-7 | Details |
| Leucoagglutinin from P. vulgaris, recombinant | Details |
| Ethyl (2-methylbenzoyl)acetate | C12H14O3 | 51725-82-7 | Details |
| Allyltriisopropylsilane | C12H26Si | 24400-84-8 | Details |
| Monoclonal Anti-PMFBP1 antibody produced in mouse | Details |
| (5Z)-3-SEC-BUTYL-5-[(1,3-DIPHENYL-1H-PYRAZOL-4-YL)METHYLENE]-2-THIOXO-1,3-THIAZOLIDIN-4-ONE | C23H21N3OS2 | 624724-34-1 | Details |
| 3-(5-(2-CHLOROPHENYL)-2-FURYL)-N-(2-METHOXYPHENYL)-2-PROPENAMIDE | C20H16ClNO3 | 853348-24-0 | Details |
| EIF2AK3 Activator, CCT020312 | C31H30Br2N4O2 | 324759-76-4 | Details |
| Transforming Growth Factor-β3 human | Details |
| 1,1'-(4-METHYL-1,3-PHENYLENE)BIS(3-BUTYLUREA) | C17H28N4O2 | 60903-52-8 | Details |
| 7-(4-CL-PH)-N-(3,4-DIMETHYL-PH)-5-((HYDRAZINO(OXO)AC)HYDRAZONO)-7-OXOHEPTANAMIDE | C23H26ClN5O4 | 883801-63-6 | Details |
| 2-CHLORO-3-(3-NITROANILINO)-1,4-NAPHTHOQUINONE | C16H9ClN2O4 | 84348-88-9 | Details |
| 7-HYDROXY-3-PHENOXY-2-TRIFLUOROMETHYL-CHROMEN-4-ONE | C16H9F3O4 | 137460-59-4 | Details |
| Anti-CLEC4C antibody produced in rabbit | Details |
| 2-{[4,5-BIS(4-CHLOROPHENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}-N'-{(E)-[4-(METHYLSULFANYL)PHENYL]METHYLIDENE}ACETOHYDRAZIDE | C24H19Cl2N5OS2 | 497248-18-7 | Details |
| 183 BLCL human cell line | Details |
| C4H7NO2 | 2133-34-8 | Details |
| METHYL 2-(3,4-DIHYDRO-3-OXO-2H-1,4-BENZOTHIAZIN-2-YL)ACRYLATE | C12H11NO3S | 200636-18-6 | Details |
| Monoclonal Anti-Asic1 antibody produced in mouse | Details |
| ETHYL 3-(4-BROMOBENZOYL)-8-CYANO-1-INDOLIZINECARBOXYLATE | C19H13BrN2O3 | 892158-78-0 | Details |
| 4-Nitrocinnamaldehyde, predominantly trans | C9H7NO3 | 49678-08-2 | Details |
| 3-{(5E)-5-[(2E)-2-METHYL-3-PHENYL-2-PROPENYLIDENE]-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-3-YL}PROPANOIC ACID | C16H15NO3S2 | 306323-56-8 | Details |
| 2-(allylamino)-2-(2-chlorophenyl)cyclohexanone hydrochloride | Details |
| 2-(dimethylamino)-2-methyl-1-(3-methylphenyl)-1-propanone hydrochloride | C13H20ClNO | Details |
| 5-(Benzoyl)-2-(4-cyanophenyl)benzimidazole | C21H13N3O | 1192541-69-7 | Details |
| 3-phenoxy-2-phenylpiperidine hydrochloride | C17H19NO.ClH | 1781419-71-3 | Details |
| RCL T254932 | Details |
| Calcium succinate | 159389-75-0 | Details |
| Monoclonal Anti-TAF5L antibody produced in mouse | Details |
| N-(2,2,2-TRICHLORO-1-(3-(4-NITRO-PHENYL)-THIOUREIDO)-ETHYL)-ACETAMIDE | 303046-60-8 | Details |
| UNG1 (AB1) Blocking Peptide for PRS3863 | Details |
| 1-Fmoc-4-piperidineacetic acid | C22H23NO4 | 180181-05-9 | Details |
| Anti-SOX15 (ab2) antibody produced in rabbit | Details |
| MAP Kinase 2/Erk2 Protein, active, mouse, 10 μg | Details |
| 5-METHYL-1-(METHYLAMINO)-5H-DIBENZ(B,E)AZEPINE-6,11-DIONE | C16H14N2O2 | 200128-49-0 | Details |
| O-(3-Carboxypropyl)-O′-[2-(3-mercaptopropionylamino)ethyl]-polyethylene glycol | (C2H4O)nC9H17NO4S | 1220112-75-3 | Details |
| (ETO-CARBONYL-4,4-DI-ME-5,5-DIPHENYL-PYRAZOL-YL)-TRIPHENYL-PHOSPHONIUM, CHLORIDE | 1098216-26-2 | Details |
| 1,3-BIS(TRIMETHYLSILYLOXY)PROPANE | C9H24O2Si2 | 17887-80-8 | Details |
| Anti-MRPL38 antibody produced in rabbit | Details |
| VEGF Inhibitor, V1 | C40H61N11O9 | Details |
| 2',6'-DIETHYL-4-METHYLBENZANILIDE | C18H21NO | 200116-58-1 | Details |
| 4-(4-CHLOROBENZYL)-N-(2-ETHOXYBENZYLIDENE)-1-PIPERAZINAMINE | C20H24ClN3O | 306989-19-5 | Details |
| Monoclonal Anti-NEK4, (C-terminal) antibody produced in mouse | Details |
| Anti-CLEC11A antibody produced in rabbit | Details |
| ETHYL 2-[(OXO{(2E)-2-[2-(TRIFLUOROMETHYL)BENZYLIDENE]HYDRAZINO}ACETYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXYLATE | C21H20F3N3O4S | 883819-69-0 | Details |
| TRIPHENYLBISMUTH BIS(2-CHLOROACETATE) | C22H19BiCl2O4 | 61217-41-2 | Details |
| Boc-Glu-OH | C10H17NO6 | 2419-94-5 | Details |
| Anti-MAP1b antibody, Mouse monoclonal | Details |
| 3-Benzyl-2,4-pentanedione | C12H14O2 | 1134-87-8 | Details |
| Anti-PPHLN1 antibody produced in rabbit | Details |
| (5E)-5-(4-ETHYLBENZYLIDENE)-2-(4-METHYLPHENYL)[1,3]THIAZOLO[3,2-B][1,2,4]TRIAZOL-6(5H)-ONE | C20H17N3OS | 606954-54-5 | Details |
| 2-(1-(2-Morpholinoethyl)-1H-benzo[d]imidazol-2-yl)ethanamine | Details |
| Anti-Cytokeratin, pan antibody, Mouse monoclonal | Details |
| 4-HO-N'-(1-ME-PROPYLIDENE)-2-OXO-1-PENTYL-1,2-DIHYDRO-3-QUINOLINECARBOHYDRAZIDE | 1227183-40-5 | Details |
| 2-METHOXY-4-(2-(PHENYLSULFONYL)CARBOHYDRAZONOYL)PHENYL 2,4-DICHLOROBENZOATE | C21H16Cl2N2O5S | 880069-01-2 | Details |
| 1-(2-Chloroethyl)-5-methyl-1H-pyrazole | C6H9ClN2 | 96450-54-3 | Details |
| 3,5-bis(4-methoxyphenyl)-4,5-dihydroisoxazole | C17H17NO3 | 20821-99-2 | Details |
| 2'-METHOXY-5'-METHYLACETOPHENONE | C10H12O2 | 20628-07-3 | Details |
| METHYL 2,4-DIMETHYL-5-{[(4-OXO-3-PHENYL-3,4,5,6,7,8-HEXAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-2-YL)SULFANYL]ACETYL}-1H-PYRROLE-3-CARBOXYLATE | C26H25N3O4S2 | 496026-02-9 | Details |
| 4-FLUORO-N-(4-OXO-2-THIOXO-THIAZOLIDIN-3-YL)-BENZAMIDE | 379256-28-7 | Details |
| 1-(10-{3-[4-(2-hydroxyethyl)-1-piperidinyl]propyl}-10H-phenothiazin-2-yl)ethanone | C24H30N2O2S | 3819-00-9 | Details |
| Lithium-6Li oxide | Details |
| SeQuant ZIC-HILIC 5μm,200 250 x 4.6 mm | Details |
| 16:0 PC-d75 | C40H80NO8P | 181041-62-3 | Details |
| 2-{(3Z)-3-[3-(2-METHOXYETHYL)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE]-2-OXO-2,3-DIHYDRO-1H-INDOL-1-YL}-N-[3-(TRIFLUOROMETHYL)PHENYL]ACETAMIDE | C23H18F3N3O4S2 | 378222-09-4 | Details |
| 2-((4-((ANILINOCARBOTHIOYL)AMINO)PHENYL)THIO)-N-(3,4-DIMETHYLPHENYL)ACETAMIDE | C23H23N3OS2 | 763128-88-7 | Details |
| Anti-N-cadherin Antibody, clone 6A9.2 | Details |
| APO-DIRECT-50T(2-8C) | Details |
| 1-Hydroxypiperidine | C5H11NO | 4801-58-5 | Details |
| 2-(2-Aminoethyl)-4-methylphenol hydrochloride | C9H14ClNO | Details |
| ISOPROPYL (2E)-2-[4-(BENZYLOXY)BENZYLIDENE]-5-(4-METHOXYPHENYL)-7-METHYL-3-OXO-2,3-DIHYDRO-5H-[1,3]THIAZOLO[3,2-A]PYRIMIDINE-6-CARBOXYLATE | C32H30N2O5S | 306982-43-4 | Details |
| ({5-[3-(3-{[(CARBOXYMETHYL)AMINO]METHYL}-4-HYDROXY-5-ISOPROPYL-2-METHYLPHENYL)-1,1-DIOXIDO-3H-2,1-BENZOXATHIOL-3-YL]-2-HYDROXY-3-ISOPROPYLBENZYL}AMINO)ACETIC ACID | 883845-96-3 | Details |
| 2-AMINO-1-(4-BROMOPHENYL)-5-OXO-4-(2-THIENYL)-1,4,5,6,7,8-HEXAHYDRO-3-QUINOLINECARBONITRILE | C20H16BrN3OS | 311316-24-2 | Details |
| N,N′-Methylenebisacrylamide ready-to-use solution "BIS" 2% | C7H10N2O2 | Details |
| Ro106-9920 | C10H7N5OS | 62645-28-7 | Details |
| Steritest? Symbio Essential Requalification Protocol | Details |
| 11-[4-(2-HYDROXYETHYL)-1-PIPERAZINYL]-7,8,9,10-TETRAHYDROBENZIMIDAZO[1,2-B]ISOQUINOLINE-6-CARBONITRILE | C22H25N5O | 459191-84-5 | Details |
| Mobius? 2000 L Power MIX carrier w/ hoist, temp sensor, load cells, ASME | Details |
| Corning? Lambda? plus 12-channel pipettor | Details |
| TSKgel? CN-80Ts HPLC Column | Details |
| (5E)-3-HEPTYL-5-{[3-(4-METHOXY-3-METHYLPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE}-2-THIOXO-1,3-THIAZOLIDIN-4-ONE | C28H31N3O2S2 | 1018005-92-9 | Details |
| MOBIUS? FlexReady Solution for XMO2 - XMO3 - Essential Service Plan execution including protocol | Details |
| Nunc? Low Profile Universal Tubes in 2D bar coded latch rack | Details |
| Anti-Neuroligin-4 | Details |
| Product Total： Product Page： | ||||
| 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 | ||||